NCT06899152 - HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

July 31, 2031

Study Completion Date

July 31, 2031

Conditions

Liver CancerHepatocellular CarcinomaHepatocellular CancerCholangiocarcinomaLiver Metastases

Interventions

DIAGNOSTIC_TEST

HepQuant DuO

HepQuant DuO is a quantitative liver function test. It assesses cholate uptake, a liver specific function. Cholate is a naturally occurring substance that is cleared by the liver. Cholate uptake reflects the health of liver cells.

OTHER

Multiparametric MRI Scans

Standard of care

Trial Locations (1)

10467

RECRUITING

Montefiore Medical Center, The Bronx